Commonly referred to as the Health Valley, Western Switzerland has made its first appearance in Startup Genome’s and the Global Entrepreneurship Network’s 2019 Life Sciences Ecosystem System Ranking. This report, involving data from over a million companies across 150 cities, aims to evaluate startup success and ecosystem performance on a global level.
In this year’s report, the Bern-Lausanne-Geneva region has ranked #9 worldwide in terms of patents, #8 for research and #7 for policy in the life sciences category.
A unique life sciences ecosystem at the heart of Western Switzerland
Western Switzerland’s Health Valley is ranked just behind Cambridge and in front of most European regions with regard to its attractiveness, which is why large multinational companies such as Merck, UCB, Baxalta and CSL Behring have chosen the region as the location for their production sites, some of the most advanced in the world. Furthermore, the Swiss life sciences sector has the highest productivity per employee in international surveys.
Technology and innovation parks, research centers, labs, equipment : Western Switzerland has the advanced infrastructure necessary for companies in the life sciences sector to develop their activities. Campus Biotech in Geneva is a center of excellence for research in biotechnology and life sciences, as is Biopôle in Lausanne, specializing in oncology, immunology and personalized medicine. In Valais, BioArk supports SMEs and start-ups in transforming their projects into industrial and commercial reality and in developing their business.